Medeon Biodesign, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 154.415 million compared to TWD 125.443 million a year ago. Operating loss was TWD 28.780 million compared to TWD 69.040 million a year ago. Net loss was TWD 63.791 million compared to TWD 69.906 million a year ago. Basic loss per share was TWD 0.96 compared to TWD 1.05 a year ago. For the nine months, sales was TWD 430.437 million compared to TWD 331.870 million a year ago. Operating loss was TWD 110.982 million compared to TWD 196.325 million a year ago. Net loss was TWD 179.324 million compared to TWD 178.614 million a year ago. Basic loss per share was TWD 2.7 compared to TWD 2.71 a year ago.